EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Biomarkers predicting the effect of anti‐TNF treatment in paediatric and adult inflammatory bowel disease

Dwight A Winter, Pauline de Bruyne, Janneke van der Woude, Dimitris Rizopoulos, Lissy de Ridder, Janneke Samsom, Johanna C Escher

Journal of Pediatric Gastroenterology and Nutrition · 2024

DOI: 10.1002/jpn3.12221 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Pediatric Gastroenterology and Nutrition, 2024. Verfasst von Dwight A Winter und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatric Gastroenterology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands. Hauptthemen laut MEDLINE: Infliximab, Biomarkers, Adalimumab, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sophia Children's Hospital Research Fund, Investigator-Initiated Studies Programme of MSD Netherlands.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Paediatric and adult inflammatory bowel disease (pIBD, aIBD) patients may lose response to anti‐tumour necrosis factor (TNF) treatment within the first year. Adult‐extrapolated weight‐based dosing is incorrect in children, due to age‐related pharmacokinetic differences. We investigated biomarkers for initial and maintenance of response to infliximab (IFX) or adalimumab (ADA), comparing pIBD and aIBD patients.

Methods

In this prospective, observational study, pIBD ( n = 24) and aIBD ( n = 21) patients were included when initiating anti‐TNF. Escalation from standard dosing and continued anti‐TNF at 12 and 18 months were assessed. Biomarkers included clinical laboratory parameters, faecal calprotectin (FCP) and IFX trough levels (TLs). Plasma proteomics was performed in pIBD.

Results

During our study, treatment escalation (in clinical loss of response) occurred more common in pIBD versus aIBD ( p = 0.02). We established that IFX therapy escalation in pIBD patients was not due to low infliximab levels. We identified 9 pro‐inflammatory proteins that were elevated in patients losing response.

Conclusion

Anti‐TNF exposure‐response relationship may be different in pIBD versus aIBD. No biomarkers for maintained response were identified, but 9 inflammatory proteins were of interest as potential predictors for loss of response in pIBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

InfliximabBiomarkersAdalimumabInflammatory Bowel DiseasesLeukocyte L1 Antigen ComplexTumor Necrosis Factor-alphaHumansProspective StudiesMaleFemaleChildAdolescentAdultFecesYoung AdultGastrointestinal AgentsTreatment Outcome

Stichwörter der Autor:innen

IBDinfliximabpharmacodynamicspharmacokinetics

Substanzen

InfliximabBiomarkersAdalimumabLeukocyte L1 Antigen ComplexTumor Necrosis Factor-alphaGastrointestinal Agents

Autor:innen und Institutionen

  • Department of Paediatric Gastroenterology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands.
  • Department of Pediatrics, Ghent University Hospital, Ghent University, Ghent, Belgium.
  • Department of Gastroenterology, Erasmus MC, Rotterdam, Netherlands.
  • Department of Biostatistics, Erasmus MC, Rotterdam, Netherlands.
  • Laboratory of Paediatrics, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands.

Förderung

  • Sophia Children's Hospital Research Fund
  • Investigator-Initiated Studies Programme of MSD Netherlands

Zitieren

APA

Winter, D. A., de Bruyne, P., van der Woude, J., Rizopoulos, D., de Ridder, L., Samsom, J., & Escher, J. C. (2024). Biomarkers predicting the effect of anti‐TNF treatment in paediatric and adult inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition. https://doi.org/10.1002/jpn3.12221

Vancouver

Winter DA, de Bruyne P, van der Woude J, Rizopoulos D, de Ridder L, Samsom J, et al. Biomarkers predicting the effect of anti‐TNF treatment in paediatric and adult inflammatory bowel disease. Journal of Pediatric Gastroenterology and Nutrition. 2024. doi:10.1002/jpn3.12221

BibTeX
@article{Winter2024,
  author = {Winter, Dwight A and de Bruyne, Pauline and van der Woude, Janneke and Rizopoulos, Dimitris and de Ridder, Lissy and Samsom, Janneke and Escher, Johanna C},
  title = {Biomarkers predicting the effect of anti‐TNF treatment in paediatric and adult inflammatory bowel disease},
  journal = {Journal of Pediatric Gastroenterology and Nutrition},
  year = {2024},
  doi = {10.1002/jpn3.12221}
}
Kostenlos starten →